Bacterial adaptation to host innate immunity responses

Current Opinion in Microbiology

Volumn 3, Issue 1, 2000, Pages 60-64

  Rhen, Mikael ^a,b   Eriksson, Sofia ^a,b   Pettersson, Sven ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; VIRULENCE FACTOR;

ADAPTATION; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; HOST RESISTANCE; INFECTION RESISTANCE; MEMBRANE STRUCTURE; METABOLIC INHIBITION; NONHUMAN; REACTION ANALYSIS; REVIEW; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 0033953759     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)00052-1     Document Type: Review

References (49)

1. Johnsson E., Thern A., Dahlbäck B., Hedén L-O., Wikström M., Lindahl G. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J Immunol. 157:1996;3021-3029.
2. Kotarsky H., Hellwage J., Johnsson E., Skerka C., Svensson H., Lindahl G., Sjöbring U., Zipfel P.F. Identification of a domain in human factor H and factor H-like protein-1 interacting with group A streptococcal M proteins. J Immunol. 160:1998;3349-3354.
3. Harhaj E.W., Sun S.C. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem. 274:1999;22911-22914.
4. Papi A., Johnston S.L. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-κB-mediated transcription. J Biol Chem. 274:1999;9707-9720.
5. Ruckdeschel K., Harb S., Roggenkamp A., Hornef M., Zumbihl R., Kohler S., Heeseman J., Rouot B. Yersinia enterocolitica impairs activation of transcription factor NF-κB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor α production. J Exp Med. 187:1998;1069-1079.
6. Hoffman J.A., Katafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science. 284:1999;1313-1318. A good review illuminating the parallels between insect and mammalian innate immunity systems, as well as structures of pattern recognition molecules. The link between innate and adaptive immunity is also discussed. A good starter for anyone just entering the field.
7. •].
8. Mercurio F., Manning A.M. Multiple signals converging on NF-κB. Curr Opin Cell Biol. 11:1999;226-232. Two well written reviews on signaling and NF-κB activation. These reviews are highly recommended for people interested in the biology of NF-κB.
9. Boland A., Cornelis G.R. Role of YopP in suppression of tumor necrosis factor α release by macrophages during Yersinia infection. Infect Immun. 66:1998;1878-1884.
10. Palmer L.E., Hobbie S., Galan J.E., Bliska J.B. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-α production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol. 27:1998;953-965.
11. Forsberg A., Rosqvist R., Wolf-Watz H. Regulation and polarized transfer of the Yersinia outer proteins (Yops) involved in antiphagocytosis. Trends Microbiol. 2:1994;14-19.
12. Bliska J.B., Galan J.E., Falkow S. Signal transduction in the mammalian cell during bacterial attachment and entry. Cell. 73:1993;903-906.
13. Meijer L.K., Schesser K., Wolf-Watz H., Sassone-Corsi P., Pettersson S. The bacterial protein YopJ abrogates multiple signal transductions pathways that converge on the transcription factor CREB. Cell Microbiol. 2000;. in press.
14. Orth K., Palmer L.E., Bao Z.Q., Stewart S., Rudolph A.E., Bliska J.B., Dixon J.E. Inhibition of the mitogen activated protein kinase-kinase superfamily by a Yersinia effector. Science. 285:1999;1920-1923. An elegant paper demonstrating that the IKK-kinase and MKK-2 kinases are targets of YopJ-mediated inhibition following infection by Yersinia.
15. Hardt W.D., Galan J.E. A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc Natl Acad Sci USA. 94:1997;9887-9892.
16. Freiberg C., Fellay R., Bairoch A., Broughton W.J., Rosenthal A., Perret X. Molecular basis of symbiosis between Rhizobium and legumes. Nature. 387:1997;394-401.
17. Fu Y., Galán J.E. A Salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature. 401:1999;293-297. While the bacteria effector protein SopE interferes with the activity of Rac-1 and Cdc42 to facilitate bacterial invasion, another bacterial protein, StpP, is secreted to counteract the effect of SopE. This paper illustrates the fine-tuning and direct evidence of a bacteria mediated regulatory loop to both activate and inactivate host response genes.
18. Hobbie S., Chen L.M., Davis R., Galán J.E. Involvement of the mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal cells. J Immunol. 159:1997;5550-5559.
19. Murray H.W., Nathan C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med. 189:1999;741-746.
20. Arias M., Rojas M., Zabaleta J., Rodriguez J.I., Paris S.C., Barrera L.F., Garcia L.F. Inhibition of virulent Mycobacterium tuberculosis by Bcg(r) and Bcg(s) macrophages correlates with nitric oxide production. J Infect Dis. 176:1997;1552-1558.
21. MacLean A., Wei X.Q., Huang H.P., Al-Alem U.A., Chan W.L., Liew F.Y. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes-simplex virus infection despite enhanced Th1 cell responses. J Gen Virol. 79:1998;825-830.
22. Marks-Konczalik J., Chu S.C., Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J Biol Chem. 273:1998;22201-22208.
23. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T.et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science. 285:1999;732-736.
24. Luckhart S., Vodovotz Y., Cui L., Rosenberg R. The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. Proc Natl Acad Sci USA. 95:1998;5700-5705.
25. Secombes C., Zou J., Daniels G., Cunningham C., Koussounadis A., Kemp G. Rainbow trout cytokine and receptor genes. Immunol Rev. 166:1998;333-340.
26. Yeh H.Y., Winslow B.J., Junker D.E., Sharma J.M. In vitro effects of recombinant chicken interferon-γ on immune cells. J Inter Cytokin Res. 19:1999;687-691.
27. Vouldoukis I., Drapier J.C., Nussler A.K., Tselentis Y., Da Silva O.A., Gentilini M., Mossalayi D.M., Monjour L., Dugas B. Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway. Antimicrob Agents Chemother. 40:1996;253-256.
28. Nozaki Y., Hasegawa Y., Ichiyama S., Nakashima I., Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun. 65:1997;3644-3647.
29. Garcia-del Portillo F., Finlay B.B. Targeting of Salmonella typhimurium to vesicels containing lysosomal membrane glycoproteins bypasses compartments with mannose-6-phosphate receptors. J Cell Biol. 129:1995;81-97.
30. Rathman M., Barker L.P., Falkow S. The unique trafficking pattern of Salmonella typhimurium-containing phagosomes in murine macrophages is independent of the mechanism of bacterial entry. Infect Immun. 65:1997;1474-1485.
31. Uchiya K., Barbieri M.A., Funato K., Shah A.H., Stahl P., Groisman E.A. A Salmonella virulence protein that inhibits cellular trafficking. EMBO J. 18:1999;3924-3933. The ability to prevent maturation of endocytic vesicles to mature phagolysosomes can be used to escape immune recognition. This mechanism is exploited by several intracellular pathogens. This paper demonstrates one underlying molecular mechanism where a bacterial protein, SpiC, can prevent phagosome-lysosome fusion.
32. Vodovotz Y., Russel D., Xie Q.W., Bogdan C., Nathan C. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J Immunol. 154:1995;2914-2925.
33. Nielsen H., Birkholz S., Andersen L.P., Moran A.P. Neutrophil activation by Helicobacter pylori lipopolysaccharides. Infect Immun. 170:1994;135-139.
34. Bliss C.M. Jr., Golenblock D.T., Keates S., Linevsky J.K., Kelly C.P. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun. 66:1998;5357-5363.
35. Khan S.A., Everest P., Servos S., Foxwell N., Zähringer U., Brade H., Rietschel E.T.h., Dougan G., Charles I.G., Maskell D.J. A lethal role for lipid A in Salmonella infections. Mol Microbiol. 29:1998;571-579. The paper describes the consequences of an altered lipopolysaccharide (LPS) structure in S. typhimurium. This observation suggests that bacteria with impaired ability to induce a host response, may have a selective advantage in the adaptation to the host.
36. Giu L., Lim K.B., Gunn J.S., Bainbridge B., Darveau R.P., Hackett M., Miller S.I. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science. 276:1997;250-253.
37. Cowley S.C., Myltseva S.V., Nano F.E. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol Microbiol. 20:1996;867-874.
38. Kwan L.Y., Isaacson R.E. Identification and characterization of a phase-variable nonfimbrial Salmonella typhimurium gene that alters O-antigen production. Infect Immun. 66:1998;5725-5730.
39. Ciacci-Woolwine F., Blomfield I.C., Richardson S.H., Mizel S.B. Salmonella flagellin induces tumor necrosis factor α in a human promonocytic cell line. Infect Immun. 66:1998;1127-1134.
40. Wyant T.L., Tanner M.K., Sztein M.B. Salmonella typhi flagellae are potent inducers of proinflammatory cytokine secretion by human monocytes. Infect Immun. 67:1999;3619-3624.
41. Bian Z. Nucleator-driven assembly of curli organelles and their pathophysiological role in E. coli septic shock [PhD Thesis]. 1999;Karolinska Institute, Stockholm.
42. Herwald H., Mörgelin M., Olsén A., Rhen M., Dahlbäck B., Müller-Esterl W., Björck L. Activation of the contact-phase system on bacterial surfaces - a clue to serious complications in infectious diseases. Nat Med. 4:1998;298-302.
43. Olsén A., Jonsson A., Normark S. Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature. 338:1989;652-655.
44. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., Covacci A. cag, a pathogenicity island of Helicobacter pylori encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA. 93:1996;14648-14653.
45. Jenks P.J., Mégraud F., Labigne A. Clinical outcome after infection with Helicobacter pylori does not appear to be reliable predicted by the presence of any of the genes of the cag pathogenicity island. Gut. 43:1998;752-758.
46. Glocker E., Lange C., Covacci A., Bereswill S., Kist M., Pahl H.L. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-κB activation. Infect Immun. 66:1998;2346-2348.
47. Mims C.A. The Pathogenesis of Infectious Disease. 1987;Academic Press, San Diego.
48. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis C: a randomised trial. Lancet. 354:1999;635-639.
49. Neurath M.F., Pettersson S., Meyer zum Buschenfelde K.H., Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med. 2:1996;998-1004.